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Abstract
The BLK and CD40 loci have been associated with Kawasaki disease (KD) in two genome-wide association studies (GWAS)
conducted in a Taiwanese population of Han Chinese ancestry (Taiwanese) and in Japanese cohorts. Here we build on these
findings with replication studies of the BLK and CD40 loci in populations of Korean and European descent. The BLK region
was significantly associated with KD susceptibility in both populations. Within the BLK gene the rs2736340-located linkage
disequilibrium (LD ) comprising the promoter and first intron was strongly associated with KD, with the combined results of
Asian studies including Taiwanese, Japanese, and Korean populations (2,539 KD patients and 7,021 controls) providing very
compelling evidence of association (rs2736340, OR = 1.498, 1.354–1.657; P= 4.74610231). We determined the percentage of
B cells present in the peripheral blood mononuclear cell (PBMC) population and the expression of BLK in the peripheral
blood leukocytes (leukocytes) of KD patients during the acute and convalescent stages. The percentage of B cells in the
PBMC population and the expression of BLK in leukocytes were induced in patients in the acute stage of KD. In B cell lines
derived from KD patients, and in purified B cells from KD patients obtained during the acute stage, those with the risk allele
of rs2736340 expressed significantly lower levels of BLK. These results suggest that peripheral B cells play a pathogenic role
during the acute stage of KD. Decreased BLK expression in peripheral blood B cells may alter B cell function and predispose
individuals to KD. These associative data suggest a role for B cells during acute KD. Understanding the functional
implications may facilitate the development of B cell-mediated therapy for KD.
Citation: Chang C-J, Kuo H-C, Chang J-S, Lee J-K, Tsai F-J, et al. (2013) Replication and Meta-Analysis of GWAS Identified Susceptibility Loci in Kawasaki Disease
Confirm the Importance of B Lymphoid Tyrosine Kinase (BLK) in Disease Susceptibility. PLoS ONE 8(8): e72037. doi:10.1371/journal.pone.0072037
Editor: Li-Min Huang, National Taiwan University Hospital, Taiwan
Received April 3, 2013; Accepted July 4, 2013; Published August 30, 2013
Copyright:  2013 Chang et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work is supported by the Academia Sinica Genomic Medicine Multicenter Study, Taiwan (40-05-GMM) and the National Science Council, Taiwan
(NSC 100-2314-B-182-061-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: chen0010@ibms.sinica.edu.tw (YTC); chchen@ibms.sinica.edu.tw (CHC); jywu@ibms.sinica.edu.tw (JYW); yiching@gate.sinica.edu.tw (YCL)
PLOS ONE | www.plosone.org 1 August 2013 | Volume 8 | Issue 8 | e72037
Introduction
Kawasaki disease (KD) (OMIM 300530) is an acute, self-limited
vasculitis predominantly affecting infants and young children [1].
The disease is characterised by prolonged fever and at least four
out of five diagnostic features: polymorphous skin rash; bilateral
conjunctival injection; erythema of the oral mucosa, lips, and
tongue; erythema and red skin on the palms of the hands and the
soles of the feet; and cervical lymphadenopathy. Coronary artery
aneurysms develop in 15–25% of untreated patients, making KD
the leading cause of acquired heart disease in children in
developed countries [2]. Treatment with intravenous immuno-
globulin (IVIG) abrogates the inflammation in approximately 80%
of affected individuals and reduces the incidence of coronary
artery lesions to ,5%. Coronary artery aneurysms may lead to
ischaemic heart disease, myocardial infarction, and sudden death.
Clinical and epidemiological findings suggest that an infectious
agent triggers an inflammatory response that leads to host immune
dysregulation in genetically predisposed individuals; however, no
pathogen has been isolated, and the aetiology of KD remains
unknown.
Multiple lines of evidence suggest that genetic determinants
contribute to KD susceptibility and outcome. Asian countries have
a much higher incidence of KD than Western countries and
Taiwan has the third-highest annual incidence rate after Japan
and Korea. Genome-wide association studies (GWAS) conducted
in Japanese [3], Han Chinese descendants in Taiwan (Taiwanese)
[4], Korean [5], and European [6] populations have identified
several biologically plausible candidates for KD susceptibility and
coronary artery lesions. SNPs in the BLK and CD40 loci have been
implicated in KD in two recent GWAS conducted in Taiwanese
and Japanese populations [3,4]. To confirm the association of BLK
and CD40 with KD, we conducted replication studies in
populations of Korean- and European-descent and performed a
meta-analysis of the current and previously published studies. The
linkage disequilibrium (LD) block, comprising the promoter region
of BLK showed the most significant association with KD in the
combined Asian studies. Additionally, we examined the percent-
age of B cells in the peripheral blood mononuclear cell (PBMC)
population and the levels of BLK expression in peripheral blood
leukocytes (leukocytes) from KD patients at different stages of
disease development. We further examined the allelic regulation of
KD-associated SNPs in BLK expression and the possible regulation
of downstream signaling of B cell receptor stimulation. Our results
suggest a possible role involvement of B cells in immune
homeostasis and KD pathogenesis.
Materials and Methods
Patients and Samples
Kawasaki disease (KD) patients and controls from populations
of Taiwanese, Korean, Japanese, and European patients have
been described in detail previously [3,4,5,6]. All KD subjects were
diagnosed according to accepted criteria for KD [7,8]. Blood
samples of different stages of KD were enrolled by Kaohsiung
Chang Gung Memorial Hospital, Kaohsiung, Taiwan, and China
Medical University Hospital, Taichung, Taiwan. The samples
were collected from patients in the acute stage (within 24 h before
IVIG treatment, KD1), after IVIG treatment (3–7 days after IVIG
treatment, KD2), and during the convalescence stage (3 weeks
after IVIG treatment, KD3). All patients were initially treated with
a single dose of IVIG (2 g/kg) over a 12 hour period. Lympho-
blastoid cell lines from KD patients were established by
transforming peripheral B lymphocytes with Epstein-Barr virus.
The age-matched febrile controls (FC) were enrolled by Kaoh-
siung Chang Gung Memorial Hospital, Kaohsiung, Taiwan. They
were admitted for upper and/or lower respiratory tract infections
(including acute bronchiolitis, acute pharyngitis, acute bronchitis,
croup, and acute tonsillitis). The studies were approved by the
institutional review boards and ethics committees of all institutions.
Written informed consent was obtained from the subjects’ parents
in accordance with institutional requirements and Declaration of
Helsinki principles.
Genotyping
The genotypes of the Taiwanese and Korean collections for the
GWAS cohorts of the study were analysed with the Affymetrix
Genome-Wide Human SNP Array 6.0 [4,5] and those of the
Japanese and European populations with Illumina Human
Hap550v3 BeadChip and Illumina Human 610K Quad Bead-
Chips, respectively [3,6]. For the replication study of the BLK SNP
rs2736340 in the Japanese populations, genotypes were detected
by direct sequencing [3]. The genotype data of rs2736340 in
Taiwanese and Japanese patients were publically available [3,4].
The three tag SNPs (rs2736340, rs6993775, and rs1382566) in
BLK selected for the replication phase in the Korean collection
were genotyped with the ABI TaqMan allelic discrimination assay.
Statistical Analysis
Genotype data of the tested SNPs in the cases and controls were
directly obtained from participating studies (Taiwanese, Korean,
and International Kawasaki studies). Cochran–Armitage trend P
values and allele frequencies were then generated based on the
genotype frequencies. The data from the Japanese study was
obtained from the authors’ previously published data [3]. A meta-
analysis was then performed using a weighted average method
with inverse-variance weights: w= 1/se2. An overall z-statistic and
P value was then calculated from the weighted average of the
individual statistics. The meta-analysis was performed with
METAL (http://www.sph.umich.edu/csg/abecasis/Metal).
Meta-analyses of the tested SNPs were carried out in three phases
based on the combined data of (1) Taiwanese and Japanese
Kawasaki GWAS; (2) all Asian studies, including Taiwanese,
Japanese, and Korean studies; and (3) all Asian studies and the
international Kawasaki study. Cross-study heterogeneity assuming
fixed effects were examined with the heterogeneity index I2,
implemented in PLINK 1.07.
PBMC Isolation, Lymphocyte Subsets, and B Cell
Preparation
The peripheral blood mononuclear cells (PBMCs) were isolated
from heparinised blood from KD patients at different stages (as
described in the Patients and Samples section) by density gradient
sedimentation using Ficoll-Hypaque (Histopaquen-1077, Sigma-
Aldrich, St. Louis, MO). The percentages of B cell (CD19+) and T
cell (CD3+) subsets were determined by multicolor flow cytometry
with a FACSCalibur (BD Biosciences) using monoclonal antibod-
ies against CD3 (UCHT1; BD Biosciences, Mississauga, Ontario,
Canada) and CD19 (clone HIB19; eBioscience). Data were
analyzed with CellQuest acquisition software (BD Biosciences). B
cells were isolated using anti-CD19-coated magnetic beads
(Dynabeads M450 Pan B; Life Technologies, NY, USA).
Real-time PCR
Total RNA from the peripheral blood leukocytes (leukocytes) of
KD patients at different stages of disease development or from
age-matched fever controls were isolated with the FavorPrep
BLK and Kawasaki Disease
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Blood/Cultured Cell Total RNA Purification Kit (Favorgen).
Total RNA samples from lymphoblastoid cell lines (peripheral B
lymphocytes transformed by Epstein-Barr virus) of different allele
types of rs2736340 established from KD patients were isolated
using TRIzol reagent (Life Technologies). Reverse transcription
was performed with the SuperScriptIII First-Strand Synthesis
System (Life Technologies). BLK mRNA expression levels were
detected by real-time RT-PCR using SYBR Green PCR Master
Mix and the ABI Prism 7900 HT Sequence Detection System
(Applied Biosystems). BLK expression levels were normalized to
18 S in the PBLs study and to GAPDH in lymphoblastoid cell
lines. The final results were presented as relative expression levels.
The primers used for amplifying BLK mRNA were 59-CTT CAC
CAT CAA AGC AGA CG-39 (forward) and 59-CTC CAG GTT
GCG GAT GAC-39 (reverse). The primers used for amplifying
18S mRNA were 59-GTA ACC CGT TGA ACC CCA TT-39
(forward) and 59-CCA TCC AAT CGG TAG TAG CG-39
(reverse). The primers used for amplifying GADPH mRNA were
59-TTC GCT CTC TGC TCC TCC TGT-39 (forward) and 59-
GCC CAA TAC GAC CAA ATC CG-39 (reverse).
Western Blot
Total protein lysates were isolated from lymphoblastoid cell
lines established from KD patients and purified B cells from acute
stage KD patients with different allele types of rs2736340. Proteins
(4–20 mg per lane) were separated by standard SDS-PAGE and
then transferred onto PVDF membranes and probed with the
following antibodies: BLK (sc-329, Santa Cruz Biotechnology),
ERK1/2 C-16 (SC-123; Santa Cruz Biotechnology), phospho-
p44/p42 MAPK (ERK1/2) Thr220/Thr204 (9101; Cell Signal-
ing), GAPDH (14C10; Cell Signaling). Horseradish peroxidase–
conjugated secondary antibodies were then used, followed by
detection with a chemiluminescence detection system (Amersham
Biosciences).
Expression Quantitative Trait Locus (eQTL) Analysis
The correlation between HapMap genotypes (HapMap3
release#3, coded according to NCBI build 36 on the forward
strand, 1.46 million SNPs) and gene expression levels (GENEVAR
project, using genome-wide expression arrays including 47294
transcripts normalized independently for each population or all
together [9]) in EBV-transformed B-cell lines from the same 270
HapMap individuals was generated using the web-based tool
SNPexp v1.2 [10] (http://app3.titan.uio.no/biotools/tool.
php?app= snpexp). The 270 HapMap individuals from 4
populations include: 45 unrelated Han Chinese in Beijing
(CHB), 45 unrelated Japanese in Tokyo (JPT), 90 (30 trios)
individuals of Utah residents with ancestry from northern and
western Europe (CEU), and 90 (30 trios) Yoruba individuals of
Ibadan, Nigeria (YRI). The correlations were analyzed with the
additive genotypic model without adjustment for multiple testing.
Results
Replication Studies in Korean and European Populations
Validate Previous Genetic Associations in KD and
Implicate an LD Region within the BLK Promoter
Both BLK and CD40 loci have been identified as having the
most significant associations with KD in two GWAS conducted in
Taiwanese and Japanese populations [3,4]. To further validate the
associations, we performed replication studies of these two loci in a
Korean cohort comprising 186 patients with KD and 600 healthy
controls, previously genotyped by Affymetrix SNP Array 6.0 for
GWAS [5]. Twelve SNPs in BLK were associated with KD in this
Korean cohort (P,0.05) (Table S1 in File S1). These significantly
associated SNPs in the BLK gene were distributed in neighbouring
LD blocks, including the promoter and intron 1 of BLK (Figure S1
in File S1). Based on LD structure (Figure S1 in File S1), we
evaluated three tag SNPs, rs2736340, rs6993775, and rs1382566,
in a separate independent Korean cohort, composed of 288
children with KD and 498 controls. These three SNPs all showed
significant associations with KD in the second Korean replication
cohort (P,0.0001; Table 1). The SNP rs2736340 located in the
LD region of the BLK promoter showed the most significant
association with KD in Korean populations. Additionally, a meta-
analysis of four independent sets from Taiwanese and Korean
populations confirmed the association (P=1.41610215; Table 1).
We then performed a meta-analysis using rs2736340 data from the
current replication studies in Korean populations with previously
published data from Taiwanese and Japanese populations. This
Asian meta-analysis gave compelling evidence of association with
KD (rs2736340, OR=1.498, 95% CI, 1.354–1.657; P=4.74 6
10231; Table 2 and Figure 1). The cross-study heterogeneity was
examined by the I2 index (see Methods). The index was I2=0.0,
suggesting low heterogeneity among these tested Asian groups.
We further examined the association of BLK and CD40 loci with
KD in a cohort of European descent comprising 405 KD patients
and 6,252 controls who were previously genotyped by Illumina
Human610K Quad BeadChips for GWAS [6]. Significant
heterogeneity among Asian- and European-descended populations
was observed (I2=32.95). Three SNPs (rs12680762, rs2736340,
and rs2628476) located in the BLK promoter region showed
significant association with KD with a P value of ,0.05 (Table S2
in File S1 and Table 2), whereas the two tagging SNPs (rs6993775
and rs1382566) located in the first intron did not show any similar
association.
The B Cell Population is Highly Induced in Peripheral
Blood Mononuclear Cells (PBMC) at the Acute Stage of
KD
BLK, a src family tyrosine kinase expressed primarily in the B
cell lineage [11], transduces signals downstream following
Figure 1. Per-cohort analysis of BLK rs2736340. Boxes indicate the
odds ratio for each cohort, and horizontal lines denote the 95%
confidence interval for the corresponding odds ratio. Diamonds
represent summary odds ratios for the respective meta-analyses. Solid
vertical line indicates an odds ratio of 1.0, and dashed vertical line
denotes the odds ratio obtained from meta-analysis of all samples.
doi:10.1371/journal.pone.0072037.g001
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stimulation of B cell receptors. It is important for establishing the B
cell repertoire during development of B cells [12], and it might also
have a role in B cell activation in peripheral blood. To determine
how B cells might correlate and functionally contribute to KD
development, we first determined the percentage of CD19+ B cells
and CD3+ T cells in the PBMC population at acute and
convalescent stages of KD. The percentage of B cells was
significantly increased during the acute stage and decreased at
Table 1. Association between genetic variants in the BLK region and KD in a combined analysis of Taiwanese and Korean
populations.
RAF
SNPs Chr Positiona Locus
Risk
Allele Control Case ORg (95%CI) P value
rs2736340 8 11381382 BLK T GWAS Taiwanb 0.722 0.797 1.514 (1.282–1.789) 8.7461027
T Replication Taiwanc 0.718 0.802 1.591 (1.235–2.051) 2.5661024
T GWAS Koread 0.694 0.766 1.446 (1.104–1.895) 5.2361023
T Replication Koreae 0.696 0.801 1.761 (1.377–2.251) 4.0361026
T Meta-Pf 1.41610215
rs6993775 8 11407398 BLK A GWAS Taiwan 0.719 0.783 1.409 (1.197–1.660) 3.8661025
T Replication Taiwan 0.726 0.797 1.486 (1.155–1.912) 1.7461023
A GWAS Korea 0.706 0.785 1.521 (1.153–2.006) 2.6261023
T Replication Korea 0.714 0.791 1.516 (1.187–1.936) 6.9161024
A Meta-P 9.21610212
rs1382566 8 11422250 BLK G GWAS Taiwan 0.738 0.800 1.418 (1.198–1.679) 4.4061025
C Replication Taiwan 0.736 0.799 1.425 (1.107–1.835) 5.6261023
G GWAS Korea 0.731 0.819 1.663 (1.240–2.232) 6.0861024
G Replication Korea 0.736 0.809 1.520 (1.183–1.954) 8.2561024
G Meta-P 1.4061025
aSNP positions are derived from NCBI human genome reference sequence Build 36.3.
b622 KD cases and 1,107 controls.
c261 KD cases and 550 controls.
d186 KD cases and 600 controls.
e288 KD cases and 498 controls.
fMeta-analyses with the Cochran–Mantel–Haenszel method.
gThese statistical values are for the allelic model. Chr, chromosome; Case RAF, risk allele frequency in KD cases; Control RAF, risk allele frequency in controls; OR, odds
ratio; 95%CI, 95% confidence interval.
doi:10.1371/journal.pone.0072037.t001
Table 2. Meta-analysis of association of rs2736340 with KD.
Marker (Allele) Collection Cases Controls
Case
RAF
Control
RAF OR (95% CI) Pa Meta-OR (95% CI) Meta-Pb
rs2736340 (C/T risk
allele: T)
GWAS Taiwan 622 1,107 0.797 0.722 1.514 (1.282–1.789) 8.7461027
Replication Taiwan 261 550 0.802 0.718 1.591 (1.235–2.05) 2.5661024
GWAS Japan 428 3,379 0.778 0.693 1.72 1.44–2.05) 1.361029
Japan follow-up 1 470 378 0.786 0.68 1.73 (1.39–2.15) 1.361026
Japan follow-up 2 284 509 0.77 0.693 1.56 (1.23–2.15) 3.161024
Summary of Taiwan
and Japan
2,65 5,923 3.97610225
GWAS Korea 186 600 0.766 0.94 1.446 (1.104–1.895) 5.2361023
Replication Korea 288 498 0.801 0.696 1.761 (1.377–2.251) 4.0361026
Summary of all Asian 2,539 7,021 1.580 (1.411–1.770) 4.741610231
European descentc 05 6252 0.290* 0.251 1.192 (1.011–1.405) 3.6661022
aThese statistical values are for the allelic model.
bMeta-analyses with the Cochran–Mantel–Haenszel method. Case RAF, risk allele frequency in KD cases; Control RAF, risk allele frequency in controls; OR, odds ratio;
95% CI, 95% confidence interval.
cT is the risk allele, and also the minor allele in European descent.
doi:10.1371/journal.pone.0072037.t002
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the convalescent stage of KD. In contrast, the percentage of T cells
was decreased in the PBMCs at the acute stage of KD (Figure 2A).
The BLK expression pattern at acute and convalescent stages in
peripheral blood leukocytes (leukocytes) correlated with the
percentage of B cells in the PBMCs (Figure 2B). To minimize
the amount of blood required in further studies, we determined the
BLK expression in the leukocytes. The expression of BLK in the
leukocytes was significantly induced at the acute stage in KD
patients compared to age-matched fever controls, and the
expression levels were decreased after IVIG treatment and further
reduced at the convalescent stage (Figure 2B). These results
strongly indicate the possible involvement of B cells in immune
homeostasis and the development of KD.
rs2736340 is Associated with BLK Expression in B Cells
To determine whether KD–associated SNPs in the BLK region
affects the transcript abundance of BLK, we examined whether
expression of BLK correlated with the genotypes of three tag SNPs
within the BLK gene in B-cell lines from 45 Han Chinese in Beijing
(CHB) individuals using a publicly available resource (web-based
tool SNPexp v1.2) that used an expression quantitative trait locus
(eQTL) generated from transformed B-cell lines by HapMap (see
Methods). The results showed that of the three tag SNPs,
rs2736340 was the most significantly associated with cis expression
of the BLK gene (P=1.37961024; Table S3 in File S1). We then
analyzed expression of BLK correlated in relation to rs2736340
genotypes in B-cell lines from Japanese in Tokyo (JPT), samples
from Utah residents with ancestry from northern and western
Europe (CEU), and samples taken from Yoruba subjects in
Ibadan, Nigeria (YRI). These analyses showed that the individuals
carrying the risk allele T of rs2736340 exhibited significantly lower
expression of BLK in most of the populations tested except for the
results from YRI parents (Table 3).
To validate the correlation between rs2736340 genotypes and
BLK expression in B cells, we examined the BLK expression in B
cell lines established from KD patients and in B cells purified from
the acute stage of KD patients. We observed that those carrying
the risk allele T of rs2736340 express lower levels of BLK
(Figure 3A and B). To determine whether BLK expression was
associated with B cell receptor downstream signaling, we
examined the phosphorylation status of ERK (extracellular
signal-regulated kinase). The activation of ERK has been shown
to be a signal integration point of downstream B cell receptor
stimulation [13]. Reduced ERK activation was observed in B cell
lines carrying the rs2736340 risk allele and with low level BLK
expression (Figure 3B, left panel). However there was no
association between ERK phosphorylation status and risk allele
of possession of the rs2736340 risk allele in primary B cells purified
from the acute stage of KD patients (Figure 3B, right panel).
Discussion
In this study, we have validated the association between
polymorphism of the BLK locus with susceptibility to KD in
Korean- and European-descended populations. We have nar-
rowed down the rs2736340-located LD block comprising the
promoter region of BLK that is most significantly associated with
KD in a meta-analysis of Asian data from Taiwanese, Japanese,
and Korean populations. Fine-mapping and sequencing studies, as
well as functional studies are required to identify and validate the
potential causal variants.
Figure 2. B cell population in peripheral blood mononuclear cells (PBMC) and BLK expression in peripheral blood leukocytes (PBLs)
induced at the acute stage of KD. (A) PBMCs were stained with anti-CD19 or anti-CD3 monoclonal antibodies, and the percentage of CD19+ B
cells and CD3+ T cells in samples taken from a patient at acute and convalescent stages of KD and from a healthy control were determined by
multicolor flow cytometry. (B) Levels of BLK expression were determined by real-time RT-PCR, and levels in KD patients were compared to those in
fever controls. Values are expressed as mean 6 standard error (SE). RNA was harvested from PBLs from KD patients at different stages of disease
development or from age-matched fever controls. KD1, n=20, before IVIG treatment (within 24 h before IVIG treatment); KD2, n= 12, after IVIG
treatment (3–7 days after IVIG treatment); and KD3, n=10, convalescence stage (3 weeks after IVIG treatment). FC, n= 19, fever controls.
doi:10.1371/journal.pone.0072037.g002
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We observed that BLK expression was significantly induced in
leukocytes at the acute stage of KD in patients and that expression
was reduced during the convalescence stage, which was correlated
with the change of B cell population in PBMCs. We also
investigated the possible regulatory role of rs2736340. A significant
association was found between rs2736340 and cis expression of the
BLK gene in transformed B-cell lines from HapMap data, in
transformed B-cell lines derived from KD patients, and in purified
B cells from patients was observed. Furthermore, we demonstrated
that the risk variant of rs2736340 in BLK was associated with
regulation of the expression of BLK and activation of B cell
receptor stimulation in the transformed B-cell lines established
from KD patients. However, due to the limited blood volumes that
could be obtained during the acute stage in pediatric KD patients,
the sample size of studies performed in primary B cells was small
and we could not discern a clear trend of the association between
risk variant of rs2736340 with the regulation of B cell receptor
stimulation. Previously, the risk allele in BLK related to systemic
lupus erythematosis has been shown to be associated with reduced
expression of the BLK mRNA transcript in transformed human B
cell lines [14]. It has been proposed that the predisposition to
autoimmunity associated with low BLK expression may reflect
involvement of the B cell repertoire established during B cell
development. Studies of the cell type-specific cis eQTL in purified
primary monocytes and B cells from 288 healthy volunteers
demonstrated that the cis-eQTL of BLK was B cell specific [15],
suggesting that the allelic regulation of BLK expression in the
peripheral blood B cells may have physiological roles in immune
homeostasis. In this study, we provide evidence linking the risk
allele in BLK to the reduced expression of BLK mRNA transcript
and protein, which might correlate with the reduced down-stream
signaling of B cell receptor stimulation in peripheral blood B cells.
These results suggest that lower expression of BLK in peripheral
blood B cells during the acute stage is associated with increased
risk of KD.
B cells are essential for humoral immunity. In addition to their
role in positively regulating immune responses by producing
antigen-specific antibody and inducing optimal CD4+ T-cell
activation, recent studies have revealed that B cells have the
ability to negatively regulate cellular immune responses and
inflammation [16]. B cells repress T cell proliferation and the
differentiation of pro-inflammatory Th1 cells through the CD40-
CD40 L dependent pathway [17]. Regulatory B cell control of
autoimmunity [18] and inflammation [19] in mice has recently
been described, and reduced or absent B cell function exacerbates
disease symptoms in autoimmune diseases and acute inflammation
[16]. In response to infectious stimuli, a pool of antigen-specific B
cells and regulatory B cells quickly proliferate and may inhibit
acute inflammation. The expression of lower levels of BLK in B
cells impairs the signaling of B cell receptor stimulation and might
affect the immune homeostasis and inflammation through two
different mechanisms. First, the deficiency of B cell receptor
stimulation can affect the antibody secretion and impair host
defense. Secondly, the decrease in regulatory B cell activation may
promote T cell proliferation and differentiation of pro-inflamma-
tory Th1 cells. Thus, both events lead to exacerbated inflamma-
tion in genetically-susceptibility KD patients. Allelic regulation of
BLK expression in specific subtypes of regulatory B cells and the
balance between effector and regulatory populations of both B
cells and T cells requires further investigation at various disease
stages of KD development.
We observed modest but significantly lower expression of BLK
in the individuals carrying risk allele rs2736340. The sequence
variations in or near the BLK gene have been shown to cosegregate
with maturity-onset diabetes of the young (MODY) in familial
studies. All variants identified from the MODY families were
associated with a 60 to 80% decrease of BLK expression [20].
However, none of the family members carrying BLK mutations
reported a history of autoimmune disorders. The specific
mutations may have tissue-specific effects. On the other hand,
the interaction between BLK with other genes and environmental
conditions may be important in the susceptibility of KD and other
autoimmune disorders.
In conclusion, we have validated the association between
polymorphisms of the BLK locus and susceptibility to KD in
Korean- and European-descended populations. Using a meta-
analysis of Asian data, we have narrowed down the region most
significantly associated with KD to the rs2736340-located LD
block comprising the promoter region of BLK. Furthermore, we
have provided evidence showing that the risk allele of rs2736340 is
associated with lower expression of BLK in peripheral blood B cells
during the acute stage of KD. Decreased BLK expression in
peripheral blood B cells may alter B cell function and predispose
individuals to KD. These associative data suggest a role for B cells
Table 3. Analysis of the correlation of genotypes of
rs2736340 in BLK region with expression levels in transformed
B cells.
SNP rs2736340 Geno C/C C/T T/T P value
CHB Counts 3 17 23 1.37961024
Freq 0.067 0.395 0.535
Mean 10.630 10.350 9.647
SD 0.583 0.470 0.644
JPT Counts 5 25 14 2.66561023
Freq 0.119 0.548 0.333
Mean 10.750 10.390 9.847
SD 0.520 0.570 0.760
CEU_parents Counts 28 26 2 1.52161024
Freq 0.500 0.464 0.004
Mean 11.170 10.580 10.270
SD 0.463 0.677 0.059
CEU_children Counts 16 6 3 5.00561026
Freq 0.640 0.240 0.120
Mean 11.070 10.280 9.465
SD 0.483 0.509 0.406
YRI_parents Counts 46 9 2 7.38761021
Freq 0.807 0.158 0.035
Mean 10.770 10.760 10.570
SD 0.599 0.601 0.154
YRI_children Counts 19 8 0 6.65461024
Freq 0.707 0.296 0
Mean 10.910 10.060 NA
SD 0.438 0.689 NA
Geno, genotypes; Freq, frequency; SD, standard deviation; CHB, 45 Han Chinese
in Beijing; JEP, 44 Japanese in Tokyo; CEU_parents; CEU_children; YRI_parents;
YRI_children; All populations, 270 individuals from 4 populations (CEU: 90 (30
trios) Utah residents with ancestry from northern and western Europe; CHB: 45
unrelated Han Chinese in Beijing; JPT: 45 unrelated Japanese in Tokyo; YRI: 90
(30 trios) Yoruba in Ibadan, Nigeria). All unrelated, 210 unrelated individuals,
including 60 Yoruba (YRI) and 60 CEPH (CEU) parents, and 90 unrelated Chinese
(CHB) and Japanese (JPT) samples.
doi:10.1371/journal.pone.0072037.t003
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during acute KD. Understanding the functional implications may
facilitate the development of B cell-mediated therapy for KD.
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